Organo Corporation operates as a water treatment engineering company in Japan and internationally. The company operates through two segments, Water Treatment Engineering Business Unit and Performance Products Business Unit. It offers pure water systems, such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop-type pure water systems, cabinet-type pure water systems, electrode ionization high-purity water systems, cartridge water purifiers, and two-stage RO systems; ultrapure water systems, including desktop and cabinet-type ultrapure water systems, and final polishing unit; and other equipment comprising alkaline electrolyzed water production equipment, homogenizers, electro conductivity meters, resistivity meters, and ion exchange filters. The company also provides water, wastewater, and RO water treatment chemicals; industrial filters consisting of micro filter, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon; and commercial water purifiers. In addition, it offers ultrapure and multi-functional water production systems, wastewater treatment systems, valuable resource recovery systems, and organic solvent refining systems for the electronics industry; water supply and sewage treatment facilities; purified water production and supply systems, UF water production and supply systems, and water for injection production and supply systems, as well as pharmaceutical water system consulting services; condensate filter, condensate demineralizer, reactor water cleanup, fuel pool cleanup, makeup water, and waste water treatment systems; and sugar refining systems and equipment. The company was formerly known as Japan Organo Co., Ltd. and changed its name to Organo Corporation in 1966. Organo Corporation was incorporated in 1941 and is headquartered in Tokyo, Japan.
Organo Dividend Announcement
• Organo announced a semi annually dividend of ¥71.00 per ordinary share which will be made payable on 2025-06-01. Ex dividend date: 2025-03-28
• Organo's trailing twelve-month (TTM) dividend yield is 1.33%
Organo Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-03-28 | ¥71.00 | semi annually | 2025-06-01 |
2024-09-27 | ¥53.00 | semi annually | 2024-12-09 |
2024-03-28 | ¥61.00 | semi annually | |
2023-09-28 | ¥41.00 | semi annually | 2023-12-04 |
2023-03-30 | ¥33.00 | semi annually | 2023-06-30 |
2022-09-29 | ¥116.00 | semi annually | 2022-12-05 |
2022-03-30 | ¥72.00 | semi annually | 2022-06-30 |
2021-09-29 | ¥72.00 | semi annually | 2021-12-06 |
2021-03-30 | ¥52.00 | semi annually | 2021-06-30 |
2020-09-29 | ¥52.00 | semi annually | 2020-12-07 |
2020-03-30 | ¥57.00 | semi annually | 2020-06-11 |
2019-09-27 | ¥47.00 | semi annually | 2019-12-09 |
2019-03-27 | ¥44.00 | semi annually | 2019-06-28 |
2018-09-26 | ¥29.00 | semi annually | 2018-12-10 |
2018-03-28 | ¥28.00 | semi annually | 2018-06-29 |
2017-09-27 | ¥5.00 | semi annually | 2017-12-04 |
2017-03-29 | ¥1.00 | semi annually | 2017-06-30 |
2016-09-28 | ¥5.00 | semi annually | |
2016-03-29 | ¥5.00 | semi annually | |
2015-09-28 | ¥4.00 | semi annually | |
2015-03-27 | ¥4.00 | semi annually | |
2014-09-26 | ¥4.00 | semi annually | |
2014-03-27 | ¥4.00 | semi annually |
Organo Dividend per year
Organo Dividend growth
Organo Dividend Yield
Organo current trailing twelve-month (TTM) dividend yield is 1.33%. Interested in purchasing Organo stock? Use our calculator to estimate your expected dividend yield:
Organo Financial Ratios
Organo Dividend FAQ
Other factors to consider when evaluating Organo as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Organo stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Organo's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Organo publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Organo distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Organo are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Organo sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Organo distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Organo declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Organo's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Organo's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.